Life Sciences

With new drugs requiring over a decade to develop at a cost of billions of dollars, today’s drug manufacturers are under pressure to move products to market faster. But, to do this, pharmas must first overcome the key challenges that prevent them from putting more of their data to use, including:

• Difficulty managing high volumes of variable data
• Slow and arduous data integration processes
• Data governance and security across collaborative efforts

Data silos are the source of these problems—leading to fragmented processes and critical information gaps across every stage of the drug lifecycle.

From R&D to supply chain, pharmacovigilance, and real world evidence generation—MarkLogic is enabling pharmas to rapidly ingest, access, and achieve insight from all of their pharmaceutical data at less cost.